TrialPsychoneuroendocrinology2020

Endogenous in-session cortisol during exposure therapy predicts symptom improvement: Preliminary results from a scopolamine-augmentation trial.

Kate R Kuhlman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.